TDP43 Monoclonal Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-52949r |
| Product Name | TDP43 Monoclonal Antibody |
| Applications |
WB
FCM
IHC-P
IHC-F
IF(IHC-P)
IF(ICC)
|
| Reactivity | Human, Mouse, Rat, Zebrafish |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | Human TDP43 between 250-350 amino acids |
| Clonality | Monoclonal |
| Clone # | 6C6 |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C for 12 months. |
| Target | |
| Gene ID | 23435 |
| Swiss Prot | Q13148 |
| Synonyms | DNA-directed RNA polymerase II subunit RPB1, DNA-directed RNA polymerase II subunit A, DNA-directed RNA polymerase III largest subunit, RNA-directed RNA polymerase II subunit RPB1, RNA polymerase II subunit B1, POLR2A |
| Background | DNA and RNA-binding protein which regulates transcription and splicing. Involved in the regulation of CFTR splicing. It promotes CFTR exon 9 skipping by binding to the UG repeated motifs in the polymorphic region near the 3'-splice site of this exon. The resulting aberrant splicing is associated with pathological features typical of cystic fibrosis. May also be involved in microRNA biogenesis, apoptosis and cell division. Can repress HIV-1 transcription by binding to the HIV-1 long terminal repeat. Stabilizes the low molecular weight neurofilament (NFL) mRNA through a direct interaction with the 3' UTR. |
| Application Dilution | |
| WB | 1:1000-5000 |
| FCM | FCM1:50-100 |
| IHC-P | IHC-P1:100-500 |
| IHC-F | IHC-F1:100-500 |
| IF(IHC-P) | IFIHC-P1:100-500 |
| IF(ICC) | IFICC1:100-500 |